Healthcare Industry News:  ConvaTec  

Devices Biopharmaceuticals Personnel

 News Release - April 17, 2006

Bristol-Myers Squibb Company Names David I. Johnson President of ConvaTec

NEW YORK, April 17 (HSMN NewsFeed) -- Bristol-Myers Squibb Company (NYSE: BMY ) announced today that David I. Johnson has been named President, ConvaTec. As president, Mr. Johnson will have responsibility for all aspects of the worldwide ConvaTec business. He will be based at ConvaTec global headquarters in Skillman, New Jersey.

"David brings strong leadership skills to this important position along with the proven ability to manage global operations," said John E. Celentano, President, Bristol-Myers Squibb Health Care Group. "His knowledge and experience will continue to further strengthen and grow the ConvaTec business on a global basis and inspire excellence among colleagues around the world."

After joining Bristol-Myers Squibb Company in 1996, Mr. Johnson held positions of increasing leadership responsibility for Zimmer in Canada and Europe. In 2000, he became part of the ConvaTec business as Vice President of North America. Mr. Johnson's most recent position with ConvaTec was Senior Vice President, Global Commercial Operations.

ConvaTec, is a world-leading manufacturer of ostomy and wound therapeutic products. ConvaTec is a Bristol-Myers Squibb Company. Bristol-Myers Squibb Company is a global pharmaceutical and related health care products company.

Source: Bristol-Myers Squibb

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.